Table of Contents Author Guidelines Submit a Manuscript
Canadian Journal of Gastroenterology and Hepatology
Volume 2018 (2018), Article ID 9531925, 7 pages
https://doi.org/10.1155/2018/9531925
Review Article

The New Era of Transplant Oncology: Liver Transplantation for Nonresectable Colorectal Cancer Liver Metastases

1Multi-Organ Transplant Unit, Department of Surgery, Toronto General Hospital, University Health Network, University of Toronto, Toronto, ON, Canada
2Division of General Surgery, Department of Surgery, Toronto General Hospital, University Health Network, University of Toronto, Toronto, ON, Canada

Correspondence should be addressed to Gonzalo Sapisochin; ac.nhu@nihcosipas.olaznog

Received 3 November 2017; Accepted 31 December 2017; Published 10 January 2018

Academic Editor: Falk Rauchfuß

Copyright © 2018 Andre Gorgen et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Ferlay, I. Soerjomataram, R. Dikshit et al., “Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012,” International Journal of Cancer, 2014. View at Publisher · View at Google Scholar
  2. Canadian Cancer Society’s Advisory Committee on Cancer Statistics, Canadian Cancer Statistics 2016, Canadian Cancer Society, Toronto, Canada.
  3. M. M. Center, A. Jemal, R. A. Smith, and E. Ward, “Worldwide variations in colorectal cancer,” CA: A Cancer Journal for Clinicians, vol. 59, no. 6, pp. 366–378, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. R. L. Siegel, K. D. Miller, and A. Jemal, “Colorectal cancer mortality rates in adults aged 20 to 54 years in the united states, 1970–2014,” Journal of the American Medical Association, vol. 318, no. 6, p. 572, 2017. View at Publisher · View at Google Scholar
  5. L. G. M. van der Geest, J. Lam-Boer, M. Koopman, C. Verhoef, M. A. G. Elferink, and J. H. W. de Wilt, “Nationwide trends in incidence, treatment and survival of colorectal cancer patients with synchronous metastases,” Clinical & Experimental Metastasis, vol. 32, no. 5, pp. 457–465, 2015. View at Publisher · View at Google Scholar · View at Scopus
  6. Y. R. B. M. van Gestel, I. H. J. T. de Hingh, M. P. P. van Herk-Sukel et al., “Patterns of metachronous metastases after curative treatment of colorectal cancer,” Cancer Epidemiology, vol. 38, no. 4, pp. 448–454, 2014. View at Publisher · View at Google Scholar · View at Scopus
  7. E. Van Cutsem, A. Cervantes, R. Adam, A. Sobrero, J. H. Van Krieken et al., “ESMO consensus guidelines for the management of patients with metastatic colorectal cancer,” Annals of Oncology, vol. 27, no. 8, pp. 1386–1422, 2016. View at Google Scholar
  8. R. L. Siegel, K. D. Miller, S. A. Fedewa et al., “Colorectal cancer statistics,” CA: A Cancer Journal for Clinicians, vol. 67, no. 3, pp. 177–193, 2017. View at Publisher · View at Google Scholar · View at Scopus
  9. A. B. Benson, T. Bekaii-Saab, E. Chan, Y. J. Chen et al., “Metastatic colon cancer, version 3.2013: featured updates to the NCCN Guidelines,” Journal of the National Comprehensive Cancer Network, vol. 11, no. 2, pp. 141–152, 2013, Quiz 152. View at Google Scholar
  10. D. L. Bartlett and E. Chu, “Can metastatic colorectal cancer be cured?” Oncology, vol. 26, no. 3, pp. 266–275, 2012. View at Google Scholar
  11. M. G. House, H. Ito, M. Gönen et al., “Survival after hepatic resection for metastatic colorectal cancer: trends in outcomes for 1,600 patients during two decades at a single institution,” Journal of the American College of Surgeons, vol. 210, no. 5, pp. 744–752, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. A. C. Wei, P. D. Greig, D. Grant, B. Taylor, B. Langer, and S. Gallinger, “Survival after hepatic resection for colorectal metastases: a 10-year experience,” Annals of Surgical Oncology, vol. 13, no. 5, pp. 668–676, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. J. N. Leal, A. K. Bressan, N. Vachharajani et al., “Time-to-surgery and survival outcomes in resectable colorectal liver metastases: a multi-institutional evaluation,” Journal of the American College of Surgeons, vol. 222, no. 5, pp. 766–779, 2016. View at Publisher · View at Google Scholar
  14. L. Viganò, L. Capussotti, R. Lapointe et al., “Early recurrence after liver resection for colorectal metastases: Risk factors, prognosis, and treatment. A LiverMetSurvey-based study of 6,025 patients,” Annals of Surgical Oncology, vol. 21, no. 4, pp. 1276–1286, 2014. View at Publisher · View at Google Scholar · View at Scopus
  15. L. C. Bredt and A. F. Rachid, “Predictors of recurrence after a first hepatectomy for colorectal cancer liver metastases: a retrospective analysis,” World Journal of Surgical Oncology, vol. 12, article 391, 2014. View at Publisher · View at Google Scholar · View at Scopus
  16. N. Devaud, Z. S. Kanji, N. Dhani et al., “Liver resection after chemotherapy and tumour downsizing in patients with initially unresectable colorectal cancer liver metastases,” HPB, vol. 16, no. 5, pp. 475–480, 2014. View at Publisher · View at Google Scholar · View at Scopus
  17. T. M. Pawlik, C. R. Scoggins, D. Zorzi et al., “Effect of Surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases,” Annals of Surgery, vol. 241, no. 5, pp. 715–724, 2005. View at Publisher · View at Google Scholar
  18. E. F. Wurster, S. Tenckhoff, P. Probst et al., “A systematic review and meta-analysis of the utility of repeated versus single hepatic resection for colorectal cancer liver metastases,” HPB, vol. 19, no. 6, pp. 491–497, 2017. View at Publisher · View at Google Scholar · View at Scopus
  19. H. K. Sanoff, D. J. Sargent, M. E. Campbell et al., “Five-year data and prognostic factor analysis of oxaliplatin and irinotecan combinations for advanced colorectal cancer: N9741,” Journal of Clinical Oncology, vol. 26, no. 35, pp. 5721–5727, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. S. Manfredi, C. Lepage, C. Hatem, O. Coatmeur, J. Faivre, and A.-M. Bouvier, “Epidemiology and management of liver metastases from colorectal cancer,” Annals of Surgery, vol. 244, no. 2, pp. 254–259, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. C. Pulitano, M. Crawford, D. Joseph, L. Aldrighetti, and C. Sandroussi, “Preoperative assessment of postoperative liver function: the importance of residual liver volume,” Journal of Surgical Oncology, vol. 110, no. 4, pp. 445–450, 2014. View at Publisher · View at Google Scholar · View at Scopus
  22. A. J. Kwong, J. C. Lai, J. L. Dodge, and J. P. Roberts, “Outcomes for liver transplant candidates listed with low model for end-stage liver disease score,” Liver Transplantation, vol. 21, no. 11, pp. 1403–1409, 2015. View at Publisher · View at Google Scholar · View at Scopus
  23. A. Umgelter, A. Hapfelmeier, W. Kopp, M. van Rosmalen, X. Rogiers, and M. Guba, “Disparities in Eurotransplant liver transplantation wait-list outcome between patients with and without model for end-stage liver disease exceptions,” Liver Transplantation, vol. 23, no. 10, pp. 1256–1265, 2017. View at Publisher · View at Google Scholar
  24. W. C. Chapman, “Liver transplantation for unresectable metastases to the liver: a new era in transplantation or a time for caution?” Annals of Surgery, vol. 257, no. 5, pp. 816-817, 2013. View at Publisher · View at Google Scholar · View at Scopus
  25. G. Sapisochin and J. Bruix, “Liver transplantation for hepatocellular carcinoma: Outcomes and novel surgical approaches,” Nature Reviews Gastroenterology & Hepatology, vol. 14, no. 4, pp. 203–217, 2017. View at Publisher · View at Google Scholar · View at Scopus
  26. V. Mazzaferro, E. Regalia, R. Doci et al., “Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis,” The New England Journal of Medicine, vol. 334, no. 11, pp. 693–699, 1996. View at Publisher · View at Google Scholar · View at Scopus
  27. W. R. Kim, J. R. Lake, J. M. Smith et al., “OPTN/SRTR 2015 Annual Data Report: Liver,” American Journal of Transplantation, vol. 17, no. S1, pp. 174–251, 2017. View at Publisher · View at Google Scholar
  28. A. Zarrinpar and R. W. Busuttil, “Liver transplantation: past, present and future,” Nature Reviews Gastroenterology & Hepatology, vol. 10, no. 7, pp. 434–440, 2013. View at Publisher · View at Google Scholar · View at Scopus
  29. I. De Vreede, J. L. Steers, P. A. Burch et al., “Prolonged disease-free survival after orthotopic liver transplantation plus adjuvant chemoirradiation for cholangiocarcinoma,” Liver Transplantation, vol. 6, no. 3, pp. 309–316, 2000. View at Publisher · View at Google Scholar · View at Scopus
  30. M. T. Austin, C. M. Leys, I. D. Feurer et al., “Liver transplantation for childhood hepatic malignancy: a review of the United Network for Organ Sharing (UNOS) database,” Journal of Pediatric Surgery, vol. 41, no. 1, pp. 182–186, 2006. View at Publisher · View at Google Scholar · View at Scopus
  31. M. Pavel, E. Baudin, A. Couvelard et al., “ENETS consensus guidelines for the management of patients with liver and other distant metastases from neuroendocrine neoplasms of foregut, midgut, hindgut, and unknown primary,” Neuroendocrinology, vol. 95, no. 2, pp. 157–176, 2012. View at Publisher · View at Google Scholar · View at Scopus
  32. T. Hibi, O. Itano, M. Shinoda, and Y. Kitagawa, “Liver transplantation for hepatobiliary malignancies: a new era of “Transplant Oncology” has begun,” Surgery Today, vol. 47, no. 4, pp. 403–415, 2017. View at Publisher · View at Google Scholar · View at Scopus
  33. F. Mühlbacher, I. Huk, R. Steininger, M. Gnant, P. Götzinger et al., “Is orthotopic liver transplantation a feasible treatment for secondary cancer of the liver?” Transplantation Proceedings, vol. 23, no. 1, part 2, pp. 1567-1568, 1991. View at Google Scholar
  34. F. Mühlbacher and F. Piza, “Orthotopic liver transplantation for secondary malignancies of the liver.,” Transplantation Proceedings, vol. 19, no. 1, pp. 2396–2398, 1987. View at Google Scholar · View at Scopus
  35. D. Moris, D. I. Tsilimigras, J. Chakedis et al., “Liver transplantation for unresectable colorectal liver metastases: A systematic review,” Journal of Surgical Oncology, vol. 116, no. 3, pp. 288–297, 2017. View at Publisher · View at Google Scholar
  36. S. Kappel, D. Kandioler, R. Steininger et al., “Genetic detection of lymph node micrometastases: a selection criterion for liver transplantation in patients with liver metastases after colorectal cancer,” Transplantation, vol. 81, no. 1, pp. 64–70, 2006. View at Publisher · View at Google Scholar · View at Scopus
  37. I. Penn, “Hepatic transplantation for primary and metastatic cancers of the liver,” Surgery, vol. 110, no. 4, pp. 726–734, 1991, Discussion 734-735. View at Google Scholar
  38. A. Foss, R. Adam, and S. Dueland, “Liver transplantation for colorectal liver metastases: Revisiting the concept,” Transplant International, vol. 23, no. 7, pp. 679–685, 2010. View at Publisher · View at Google Scholar · View at Scopus
  39. E. Hoti and R. Adam, “Liver transplantation for primary and metastatic liver cancers,” Transplant International, vol. 21, no. 12, pp. 1107–1117, 2008. View at Publisher · View at Google Scholar · View at Scopus
  40. M. H. Andersen, S. Dueland, M. Hagness et al., “Quality of life following liver transplantation in patients with liver metastases from colorectal carcinoma,” Scandinavian Journal of Caring Sciences, vol. 26, no. 4, pp. 713–719, 2012. View at Publisher · View at Google Scholar · View at Scopus
  41. M. Hagness, A. Foss, P.-D. Line, T. Scholz et al., “Liver transplantation for nonresectable liver metastases from colorectal cancer,” Annals of Surgery, vol. 257, no. 5, pp. 800–806, 2013. View at Publisher · View at Google Scholar
  42. C. Toso, H. Pinto Marques, A. Andres et al., “Liver transplantation for colorectal liver metastasis: Survival without recurrence can be achieved,” Liver Transplantation, vol. 23, no. 8, pp. 1073–1076, 2017. View at Publisher · View at Google Scholar
  43. A. S. Lucas, B. H. O'Neil, and R. M. Goldberg, “A decade of advances in cytotoxic chemotherapy for metastatic colorectal cancer,” Clinical Colorectal Cancer, vol. 10, no. 4, pp. 238–244, 2011. View at Publisher · View at Google Scholar · View at Scopus
  44. M. Hagness, A. Foss, T. S. Egge, and S. Dueland, “Patterns of recurrence after liver transplantation for nonresectable liver metastases from colorectal cancer,” Annals of Surgical Oncology, vol. 21, no. 4, pp. 1323–1329, 2014. View at Publisher · View at Google Scholar · View at Scopus
  45. J. Bellier, J. De Wolf, M. Hebbar et al., “Repeated resections of hepatic and pulmonary metastases from colorectal cancer provide long-term survival,” World Journal of Surgery, pp. 1–9, 2017. View at Publisher · View at Google Scholar
  46. M. D'Angelica, P. Kornprat, M. Gonen et al., “Effect on outcome of recurrence patterns after hepatectomy for colorectal metastases,” Annals of Surgical Oncology, vol. 18, no. 4, pp. 1096–1103, 2011. View at Publisher · View at Google Scholar · View at Scopus
  47. S. Dueland, T. K. Guren, M. Hagness, B. Glimelius, P.-D. Line et al., “Chemotherapy or liver transplantation for nonresectable liver metastases from colorectal cancer?” Annals of Surgery, vol. 261, no. 5, pp. 956–960, 2015. View at Publisher · View at Google Scholar
  48. K. M. Tveit, T. Guren, B. Glimelius et al., “Phase III trial of cetuximab with continuous or intermittent fluorouracil, leucovorin, and oxaliplatin (Nordic FLOX) versus FLOX alone in first-line treatment of metastatic colorectal cancer: the NORDIC-VII study,” Journal of Clinical Oncology, vol. 30, no. 15, pp. 1755–1762, 2012. View at Publisher · View at Google Scholar
  49. T. C. Chua, W. Liauw, F. Chu, and D. L. Morris, “Viewing metastatic colorectal cancer as a curable chronic disease,” American Journal of Clinical Oncology, vol. 35, no. 1, pp. 77–80, 2012. View at Publisher · View at Google Scholar · View at Scopus
  50. I. Grossmann, P. M. Doornbos, J. M. Klaase, G. H. De Bock, and T. Wiggers, “Changing patterns of recurrent disease in colorectal cancer,” European Journal of Surgical Oncology, vol. 40, no. 2, pp. 234–239, 2014. View at Publisher · View at Google Scholar · View at Scopus
  51. R. Adam, D. A. Wicherts, R. De Haas et al., “Patients with initially unresectable colorectal liver metastases: Is there a possibility of cure?” Journal of Clinical Oncology, vol. 27, no. 11, pp. 1829–1835, 2009. View at Publisher · View at Google Scholar · View at Scopus
  52. U. Leung, M. Gönen, P. J. Allen et al., “Colorectal cancer liver metastases and concurrent extrahepatic disease treated with resection,” Annals of Surgery, vol. 265, no. 1, pp. 158–165, 2017. View at Publisher · View at Google Scholar · View at Scopus
  53. E. K. Abdalla, T. W. Bauer, Y. S. Chun, M. D’Angelica, D. A. Kooby, and W. R. Jarnagin, “Locoregional surgical and interventional therapies for advanced colorectal cancer liver metastases: expert consensus statements,” HPB, vol. 15, no. 2, pp. 119–130, 2013. View at Publisher · View at Google Scholar · View at Scopus
  54. V. M. Zaydfudim, T. L. McMurry, A. M. Harrigan et al., “Improving treatment and survival: a population-based study of current outcomes after a hepatic resection in patients with metastatic colorectal cancer,” HPB, vol. 17, no. 11, pp. 1019–1024, 2015. View at Publisher · View at Google Scholar · View at Scopus
  55. P. Dutkowski and P.-A. Clavien, “Solutions to shortage of liver grafts for transplantation,” British Journal of Surgery, vol. 101, no. 7, pp. 739–741, 2014. View at Publisher · View at Google Scholar · View at Scopus
  56. P. N. Aguiar Martins, B. Movahedi, and A. Bozorgzadeh, “Liver transplantation for unresectable colorectal cancer liver metastases: a paradigm change?” Annals of Surgery, vol. 262, no. 1, p. e12, 2015. View at Publisher · View at Google Scholar · View at Scopus
  57. R. M. Merion, S. J. Pelletier, N. Goodrich, M. J. Englesbe, and F. L. Delmonico, “Donation after cardiac death as a strategy to increase deceased donor liver availability,” Annals of Surgery, vol. 244, no. 4, pp. 555–560, 2006. View at Publisher · View at Google Scholar · View at Scopus
  58. S. Emre, M. E. Schwartz, G. Altaca et al., “Safe use of hepatic allografts from donors older than 70 years,” Transplantation, vol. 62, no. 1, pp. 62–65, 1996. View at Publisher · View at Google Scholar · View at Scopus
  59. L. McCormack, P. Dutkowski, A. M. El-Badry, and P.-A. Clavien, “Liver transplantation using fatty livers: always feasible?” Journal of Hepatology, vol. 54, no. 5, pp. 1055–1062, 2011. View at Publisher · View at Google Scholar · View at Scopus
  60. D. Monbaliu, J. Pirenne, and D. Talbot, “Liver transplantation using donation after cardiac death donors,” Journal of Hepatology, vol. 56, no. 2, pp. 474–485, 2012. View at Publisher · View at Google Scholar · View at Scopus
  61. P. A. Vagefi, J. Parekh, N. L. Ascher, J. P. Roberts, and C. E. Freise, “Outcomes with split liver transplantation in 106 recipients: The University of California, San Francisco, experience from 1993 to 2010,” JAMA Surgery, vol. 146, no. 9, pp. 1052–1059, 2011. View at Publisher · View at Google Scholar · View at Scopus
  62. G. Citerio, M. Cypel, G. J. Dobb et al., “Organ donation in adults: a critical care perspective,” Intensive Care Medicine, vol. 42, no. 3, pp. 305–315, 2016. View at Publisher · View at Google Scholar
  63. C. M. Miller, F. Durand, J. K. Heimbach et al., “The International Liver Transplant Society Guideline on Living Liver Donation,” Transplantation, vol. 100, no. 6, pp. 1238–1243, 2016. View at Publisher · View at Google Scholar · View at Scopus
  64. G. Sapisochin, N. Goldaracena, J. M. Laurence, G. A. Levy, D. R. Grant, and M. S. Cattral, “Right lobe living-donor hepatectomy-the Toronto approach, tips and tricks,” Hepatobiliary Surgery and Nutrition, vol. 5, no. 2, pp. 118–126, 2016. View at Google Scholar
  65. G. Sapisochin, “University Health Network, Toronto. Assessment of a protocol using a combination of neo-adjuvant chemotherapy plus living donor liver transplantation for non-resectable liver metastases from colorectal cancer,” (2016, 2017 Oct 10), https://clinicaltrials.gov/ct2/show/NCT02864485.
  66. F. Rössler, G. Sapisochin, G. Song et al., “Defining benchmarks for major liver surgery: a multicenter analysis of 5202 living liver donors,” Annals of Surgery, vol. 264, no. 3, pp. 492–500, 2016. View at Publisher · View at Google Scholar
  67. Z. Kadry, L. Mc Cormack, and P.-A. Clavien, “Should living donor liver transplantation be part of every liver transplant program?” Journal of Hepatology, vol. 43, no. 1, pp. 32–37, 2005. View at Publisher · View at Google Scholar · View at Scopus
  68. S. Dueland, “Oslo University Hospital, Oslo. A randomized controlled clinical trial to evaluate the benefit and efficacy of liver transplantation as treatment for selected patients with liver metastases from colorectal carcinoma,” (2011, 2017 Oct 10), https://clinicaltrials.gov/ct2/show/NCT01479608.
  69. S. Dueland, “Oslo University Hospital, Oslo. A Phase I/II clinical trial to evaluate the benefit and efficacy of liver resection and partial liver segment 2/3 transplantation with delayed total hepatectomy as treatment for selected patients with liver metastases from colorectal carcinoma,” (2014, 2017 Oct 10), https://clinicaltrials.gov/ct2/show/NCT02215889.
  70. P.-D. Line, M. Hagness, A. E. Berstad, A. Foss, and S. Dueland, “A novel concept for partial liver transplantation in nonresectable colorectal liver metastases: the RAPID concept,” Annals of Surgery, vol. 262, no. 1, pp. e5–e9, 2015. View at Publisher · View at Google Scholar · View at Scopus
  71. R. Adam, “Paul Brousse Hospital, Villejuif. Curative potential of liver transplantation in patients with definitively unresectable colorectal liver metastases (CLM) treated by chemotherapy: a prospective multicentric randomized trial,” (2015, 2017 Oct 10), https://clinicaltrials.gov/ct2/show/NCT02597348.
  72. S. R. Knight, P. J. Morris, S. Schneeberger, and L. H. M. Pengel, “Trial design and endpoints in clinical transplant research,” Transplant International, vol. 29, no. 8, pp. 870–879, 2016. View at Publisher · View at Google Scholar · View at Scopus